Carolinas Medical Center is an 874-bed non-profit, tertiary, research and academic medical center located in Charlotte, North Carolina, servicing the southern North Carolina, northern South Carolina, and the Metrolina region.

There are 874 beds in Atrium Health.

During the past decade, Atrium Health conducted 98 clinical trials. In the 10-year time frame, 98 clinical trials started and 34 clinical trials were completed, i.e. on average, 34.7% percent of trials that started reached the finish line to date. In the past 5 years, 46 clinical trials started and 26 clinical trials were completed. i.e. 56.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Atrium Health" #1 sponsor was "Wake Forest University Health Sciences" with 19 trials, followed by "Bristol-Myers Squibb" with 6 trials sponsored, "Eli Lilly and Company" with 5 trials sponsored, "Edwards Lifesciences" with 4 trials sponsored and "Bayer" with 4 trials sponsored. Other sponsors include 77 different institutions and companies that sponsored additional 71 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Atrium Health" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 7 trials as a collaborator, "Wake Forest University Health Sciences" with 6 trials as a collaborator, "COPD Foundation" with 3 trials as a collaborator, "Duke University" with 3 trials as a collaborator and "High Plains Research Network" with 3 trials as a collaborator. Other collaborators include 57 different institutions and companies that were collaborators in the rest 54 trials.

According to Clinical.Site data, the most researched conditions in "Atrium Health" are "Chronic Obstructive Pulmonary Disease (COPD)" (3 trials), "Multiple Myeloma" (3 trials), "Aortic Stenosis" (2 trials), "Aortic Stenosis, Severe" (2 trials) and "Asthma" (2 trials). Many other conditions were trialed in "Atrium Health" in a lesser frequency.

Most popular intervention types in "Atrium Health" are "Drug" (55 trials), "Device" (30 trials), "Other" (16 trials), "Procedure" (9 trials) and "Biological" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Dexamethasone" (4 trials), "Eculizumab" (2 trials), "HYQVIA" (2 trials) and "Hybrid Fractional Laser" (2 trials). Other intervention names were less common.

The vast majority of trials in "Atrium Health" are 101 trials for "All" genders, 16 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 43 active trials in "Atrium Health". 1 are not yet recruiting, 24 are recruiting, 16 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 56 completed trials in Atrium Health, 1 suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Atrium Health, 10 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 36 trials that are defined as “Not Applicable".